FDA clears Tekmira Phase 1 trial
September 7, 2010 by stephenkilmer · Leave a Comment
Tekmira Pharmaceuticals (TSX:TKM) has been cleared by the FDA to begin a Phase 1 human trial of its TKM-PLK1 treatment for patients with advanced solid tumour cancers, who are not well served by current therapy. The trial is scheduled to start before the end of 2010. It is designed to evaluate the safety, tolerability and [...]
Listen to BioTuesdays 
